IT Infrastructure of e-Health of the Republic of Kazakhstan

Kalimoldayev, Maksat; Belginova, Saule; Uvaliyeva, Indira; Ismukhamedova, Aigerim

doi:10.1007/978-3-030-12203-4_6

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To date, Kazakhstan has well developed electronic healthcare system among many other countries [6,7]. This is so called Unified National Electronic Health System (UNEHS), which started in 2003 and established in 2014, made available medical claims from different electronic data sources such as inpatient electronic registries of hospitalized patients, outpatients electronic registries of dispensary patients and many others, which are implemented overall all medical organizations in the country.…”

Section: Introductionmentioning

confidence: 99%

“…This is so called Unified National Electronic Health System (UNEHS), which started in 2003 and established in 2014, made available medical claims from different electronic data sources such as inpatient electronic registries of hospitalized patients, outpatients electronic registries of dispensary patients and many others, which are implemented overall all medical organizations in the country. Aggregation and utilization of such nationwide electronic healthcare data could provide real knowledge on in-depth epidemiology of diabetes in overall Kazakhstan [6,7].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019

et al. 2022

View full text Add to dashboard Cite

Background We aimed to explore descriptive epidemiology of T1 and T2 Diabetes Mellitus (DM) and to investigate demographic factors and comorbidities associated with all-cause mortality by aggregating and utilizing large-scale administrative healthcare data from the Unified National Electronic Health System (UNEHS) of Kazakhstan for 2014–2019 years period. Methods A total of 475,539 individuals were included in the analyses. The median years of follow-up for Type 1 DM patients accounted for 4.7 years and 4.5 years in Type 2 DM patients. We used Kaplan-Meier and log-rank test to calculate failure function and differences in survival by age, sex, ethnicity, and comorbidities with all-cause mortality for Type 1 and Type 2 DM. Cox proportional hazards regression analysis was used to obtain crude and adjusted hazard ratios. Results Prevalence of Type 1 and Type 2 DM increased 1.7 times from 2014 to 2019. Mortality of Type 1 and Type 2 DM also increased 4 times and 6 times from 2014 to 2019, respectively. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh in patients with Type 1 and Type 2 DM. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death. Conclusion The prevalence and mortality rate of Type 1 and Type 2 DM increased during the years 2014–2019 in Kazakhstan. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019

et al. 2022

View full text Add to dashboard Cite

show abstract

“…To date, Kazakhstan has well developed electronic healthcare system among many other countries (6,7). This is so called Uni ed National Electronic Health System (UNEHS), which started in 2003 and established in 2014, made available medical claims from different electronic data sources such as inpatient electronic registries of hospitalized patients, outpatients electronic registries of dispensary patients and many others, which are implemented overall all medical organizations in the country.…”

Section: Introductionmentioning

confidence: 99%

“…This is so called Uni ed National Electronic Health System (UNEHS), which started in 2003 and established in 2014, made available medical claims from different electronic data sources such as inpatient electronic registries of hospitalized patients, outpatients electronic registries of dispensary patients and many others, which are implemented overall all medical organizations in the country. Aggregation and utilization of such nationwide electronic healthcare data could provide real knowledge on in-depth epidemiology of diabetes in overall Kazakhstan (6,7). Therefore, we aimed to explore descriptive epidemiology of T1DM and T2DM and to investigate demographic factors associated with all-cause mortality among T1DM and T2DM.…”

Section: Introductionmentioning

confidence: 99%

Epidemiology of Type 1 and Type 2 Diabetes Mellitus in Kazakhstan: Data from Unified National Electronic Health System 2014-2019

Gaipov

Galiyeva

Gusmanov

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: We aimed to explore descriptive epidemiology of T1 and T2 Diabetes Mellitus (DM) and to investigate demographic factors and comorbidities associated with all-cause mortality by aggregating and utilizing large-scale administrative healthcare data from the Unified National Electronic Health System (UNEHS) for 2014-2019 years period.Methods: We used Kaplan-Meier and log-rank test to calculate failure function and differences in survival by age, sex, ethnicity, and comorbidities with all-cause mortality for Type 1 and Type 2 DM. Cox proportional hazards regression analysis was used to obtain crude and adjusted hazard ratios.Results: Prevalence of Type 1 and Type 2 DM increased 1.7 times from 2014 to 2019. Mortality of Type 1 and Type 2 DM also increased 4 times and 6 times from 2014 to 2019, respectively. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh in patients with Type 1 and Type 2 DM. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death. Conclusion: The prevalence and mortality rate of Type 1 and Type 2 DM increased during the years 2014 - 2019 in Kazakhstan. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death.

show abstract

Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018

et al. 2020

View full text Add to dashboard Cite

Background The epidemiology of dialysis patients has been little studied in developing countries and economies in transition. We examined the prevalence, incidence and mortality rate of dialysis patients in Kazakhstan, via aggregation and utilization of large-scale administrative healthcare data. Methods The registry data of 8898 patients receiving dialysis therapy between 2014 and 2018 years were extracted from the Unified National Electronic Health System (UNEHS) and linked with the national population registry of Kazakhstan. We provide descriptive statistics of demographic, comorbidity and dialysis-related characteristics. Results Among all patients undergoing maintenance dialysis for end-stage renal disease (ESRD), there were 3941 (44%) females and 4957 (56%) males. 98.7% of patients received hemodialysis and 1.3% peritoneal dialysis. The majority of the patients (63%) were ethnic Kazakhs, 18% were Russians and 19% were of other ethnicities. The prevalence and incidence rate in 2014 were 135.2 and 68.9 per million population (PMP), respectively, which were different in 2018 [350.2 and 94.9 PMP, respectively]. Overall mortality rate among dialysis patients reduced from 1667/1000 patient-years [95%Confidence Interval (CI): 1473–1886] (PY) in 2014 to 710/1000PY [95%CI: 658–767] in 2018. We observed 13% lower crude survival probability in females compared to males and in older patients compared to younger ones. Russian ethnicity had 58% higher risk of death, while other ethnicities had 34% higher risk of death compared to in those of Kazakh ethnicity. Conclusion We describe for the first time in Kazakhstan an increase in the prevalence and incidence of ESRD on dialysis, while mortality rate decreased over time, during 2014–2018. We observed statistically significant lower survival probability in female dialysis patients compared to males, in older patients compared to younger ones, and in patients of Russian ethnicity compared to Kazakh.

show abstract

IT Infrastructure of e-Health of the Republic of Kazakhstan

Cited by 3 publications

References 0 publications

Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019

Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019

Epidemiology of Type 1 and Type 2 Diabetes Mellitus in Kazakhstan: Data from Unified National Electronic Health System 2014-2019

Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018

Contact Info

Product

Resources

About